|
Source: Sonja Begemann, AGWEB, 8/23/18
After two long years of waiting, Bayer and Monsanto executives sit together at the table as one team. Until last week, the companies could not share business information as a condition of the Department of Justice requirements for the acquisition. The $66 billion acquisition joins together two powerhouses: Bayer’s chemical portfolio and Monsanto’s seed and trait engine. The company divested more than $7 billion in assets, including the Bayer row crop and vegetable seeds business, glufosinate business, certain glyphosate businesses and several other assets to gain access to Monsanto.
For more of this story, click here.
|